Lyphe Group (“Lyphe”), one of the UK’s leading medical cannabis companies, is pleased to announce an innovative partnership set to
PRESS RELEASE New capital raise to fund operations through to becoming cash flow positive Supply chain consolidation and below-the-line efficiencies
PRESS RELEASE Lyphe Group, the UK’s leading medical cannabis company, has announced an exclusive partnership with Cronos Australia Limited’s (“Cronos”)
PRESS RELEASE CANNIM has today announced a world first as it releases its Jamaican grown medical cannabis for patients in
LONDON-based Lyphe Group has signed an agreement to acquire Materia for an undisclosed sum, with the new combination expected to
A NEW clinic giving islanders the opportunity to be prescribed medical cannabis is opening its doors in St Martin this
LYPHE Group has announced the successful closure of its latest funding round, securing £5m in capital to fund expansion into
At Akanda, Dr. Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking
IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
